REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 222 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $2,389,579 | -61.7% | 271,852 | -50.1% | 0.01% | -71.0% |
| Q3 2023 | $6,244,807 | -42.8% | 544,447 | +26.3% | 0.03% | -39.2% |
| Q2 2023 | $10,911,040 | +105.3% | 431,096 | +161.2% | 0.05% | +96.2% |
| Q1 2023 | $5,315,487 | +11.0% | 165,026 | -36.4% | 0.03% | -3.7% |
| Q4 2022 | $4,789,502 | -67.7% | 259,453 | -52.7% | 0.03% | -66.2% |
| Q3 2022 | $14,812,000 | +253.6% | 548,607 | +81.0% | 0.08% | +263.6% |
| Q2 2022 | $4,189,000 | +3.9% | 303,076 | +46.6% | 0.02% | -4.3% |
| Q1 2022 | $4,033,000 | +12.8% | 206,805 | -5.6% | 0.02% | +15.0% |
| Q4 2021 | $3,575,000 | +1652.5% | 219,043 | +1492.2% | 0.02% | +233.3% |
| Q1 2020 | $204,000 | -19.7% | 13,757 | -29.5% | 0.01% | +50.0% |
| Q3 2019 | $254,000 | -20.1% | 19,522 | -3.1% | 0.00% | -60.0% |
| Q1 2019 | $318,000 | – | 20,151 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,592,047 | $121,230,000 | 21.92% |
| Rhenman & Partners Asset Management AB | 220,000 | $5,808,000 | 0.83% |
| ArrowMark Colorado Holdings LLC | 2,045,862 | $54,011,000 | 0.67% |
| Vivo Capital, LLC | 77,373 | $2,043,000 | 0.52% |
| Ghost Tree Capital, LLC | 89,295 | $2,357,000 | 0.49% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 124,932 | $3,298,000 | 0.47% |
| Polar Capital LLP | 1,296,371 | $34,220,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 70,095 | $1,851,000 | 0.24% |
| EAM Investors, LLC | 33,897 | $895,000 | 0.15% |
| PointState Capital LP | 438,200 | $11,568,000 | 0.13% |